Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Proquest Summons
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 30 | 13 | 4 | 7 |
Year wise citations received |
59 | 69 | 60 | 48 | 62 |
| Journal total citations count | 548 |
| Journal Impact Factor | 2.31 |
| Journal 5 years Impact Factor | 3.74 |
| Journal CiteScore | 4.86 |
| Journal h-index | 12 |
Important citations
Redox Biology of Respiratory Viral Infections.
Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates
SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics
Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women
OXIDATIVE STRESS AND CYTOKINES’ INVOLVEMENT IN THE OCCURENCE AND PROGRESSION OF DIABETIC COMPLICATIONS IN THE COVID-19 PANDEMIC CONTEXT
Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women
Oxidative stress and inflammatory biomarkers for the prediction of severity and ICU admission in unselected patients hospitalized with COVID-19
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic
Should we unstress SARS-CoV-2 infected cells?
NOX-dependent signaling dysregulation in severe COVID-19: clues to effective treatments
COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach
The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells
Oxidative stress markers in infectious respiratory diseases: current clinical practice
Phenotypical characterization of human rhinovirus infections in severely premature children
Morning sickness in pregnancy: mini review of possible causes with proposal for monitoring by diagnostic methods
Odoriferous therapy: a review identifying essential oils against pathogens of the respiratory tract
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Suppression of nuclear factor erythroid?2?related factor 2?mediated antioxidative defense in the lung injury induced by chronic exposure to methamphetamine in rats
Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities